Your browser doesn't support javascript.
loading
Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs.
Kalter, J; Verdonck-de Leeuw, I M; Sweegers, M G; Aaronson, N K; Jacobsen, P B; Newton, R U; Courneya, K S; Aitken, J F; Armes, J; Arving, C; Boersma, L J; Braamse, A M J; Brandberg, Y; Chambers, S K; Dekker, J; Ell, K; Ferguson, R J; Gielissen, M F M; Glimelius, B; Goedendorp, M M; Graves, K D; Heiney, S P; Horne, R; Hunter, M S; Johansson, B; Kimman, M L; Knoop, H; Meneses, K; Northouse, L L; Oldenburg, H S; Prins, J B; Savard, J; van Beurden, M; van den Berg, S W; Brug, J; Buffart, L M.
Afiliação
  • Kalter J; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Verdonck-de Leeuw IM; Department of Clinical Psychology, VU University Amsterdam, The Netherlands.
  • Sweegers MG; Department of Otolaryngology-Head and Neck Surgery, Amsterdam Public Health research institute and Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Aaronson NK; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
  • Jacobsen PB; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Newton RU; Division of Cancer Control and Population Science, National Cancer Institute, Bethesda, Maryland, FL, USA.
  • Courneya KS; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.
  • Aitken JF; Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada.
  • Armes J; Menzies Health Institute Queensland, Griffith University, Southport, Australia.
  • Arving C; Cancer Council Queensland, Brisbane, Australia.
  • Boersma LJ; Institute for Resilient Regions, University of Southern Queensland, Brisbane, Australia.
  • Braamse AMJ; Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
  • Brandberg Y; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Chambers SK; Department of Radiation Oncology, Maastricht University Medical Center (MAASTRO clinic), Maastricht, The Netherlands.
  • Dekker J; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Ell K; Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.
  • Ferguson RJ; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Gielissen MFM; Menzies Health Institute Queensland, Griffith University, Southport, Australia.
  • Glimelius B; Cancer Council Queensland, Brisbane, Australia.
  • Goedendorp MM; Prostate Cancer Foundation of Australia, Sydney, NSW, Australia.
  • Graves KD; Department of Rehabilitation Medicine, VU University Medical Center, Amsterdam, The Netherlands.
  • Heiney SP; Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
  • Horne R; Department of Adults and Healthy Aging, University of Southern California, Los Angeles, CA, USA.
  • Hunter MS; Division of Hematology-Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Johansson B; Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.
  • Kimman ML; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Knoop H; Department of Health Psychology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Meneses K; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Northouse LL; College of Nursing, University of South Carolina, Columbia, SC, USA.
  • Oldenburg HS; UCL School of Pharmacy, University College London, London, UK.
  • Prins JB; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Savard J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • van Beurden M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • van den Berg SW; Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.
  • Brug J; University of Alabama at Birmingham, School of Nursing, Birmingham, AL, USA.
  • Buffart LM; University of Michigan School of Nursing, Ann Arbor, MI, USA.
Psychooncology ; 27(4): 1150-1161, 2018 04.
Article em En | MEDLINE | ID: mdl-29361206
ABSTRACT

OBJECTIVE:

This individual patient data (IPD) meta-analysis aimed to evaluate the effects of psychosocial interventions (PSI) on quality of life (QoL), emotional function (EF), and social function (SF) in patients with cancer, and to study moderator effects of demographic, clinical, personal, and intervention-related characteristics.

METHODS:

Relevant studies were identified via literature searches in 4 databases. We pooled IPD from 22 (n = 4217) of 61 eligible randomized controlled trials. Linear mixed-effect model analyses were used to study intervention effects on the post-intervention values of QoL, EF, and SF (z-scores), adjusting for baseline values, age, and cancer type. We studied moderator effects by testing interactions with the intervention for demographic, clinical, personal, and intervention-related characteristics, and conducted subsequent stratified analyses for significant moderator variables.

RESULTS:

PSI significantly improved QoL (ß = 0.14,95%CI = 0.06;0.21), EF (ß = 0.13,95%CI = 0.05;0.20), and SF (ß = 0.10,95%CI = 0.03;0.18). Significant differences in effects of different types of PSI were found, with largest effects of psychotherapy. The effects of coping skills training were moderated by age, treatment type, and targeted interventions. Effects of psychotherapy on EF may be moderated by cancer type, but these analyses were based on 2 randomized controlled trials with small sample sizes of some cancer types.

CONCLUSIONS:

PSI significantly improved QoL, EF, and SF, with small overall effects. However, the effects differed by several demographic, clinical, personal, and intervention-related characteristics. Our study highlights the beneficial effects of coping skills training in patients treated with chemotherapy, the importance of targeted interventions, and the need of developing interventions tailored to the specific needs of elderly patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psicoterapia / Qualidade de Vida / Ajustamento Social / Ajustamento Emocional / Reabilitação Psiquiátrica / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Psychooncology Assunto da revista: NEOPLASIAS / PSICOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psicoterapia / Qualidade de Vida / Ajustamento Social / Ajustamento Emocional / Reabilitação Psiquiátrica / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Psychooncology Assunto da revista: NEOPLASIAS / PSICOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda